- Intel sees an adjusted EPS of 10c in the second quarter, which is lower than the estimated 24c.
- The company reported $12.72 billion in revenue for the first quarter, slightly beating the earlier estimate of $12.71 billion.
- Intel’s adjusted gross margin for the first quarter was 45.1%, slightly above the estimated 44.5%.
- Their R&D expenses for the same period amounted to $4.38 billion, constituting a significant increase from the estimated $3.86 billion.
- Adjusted operating income for the first quarter was reported at $723 million, surpassing the estimated $562.1 million.
- The adjusted operating margin was at 5.7%, compared to the estimated 4.78%.
- Intel’s Products revenue was $11.93 billion and Datacenter & AI revenue was $3.0 billion.
- Intel forecasts its second-quarter 2024 revenue to fall within the range of $12.5 billion to $13.5 billion.
- They expect second-quarter EPS to be $(0.05), with a non-GAAP EPS of $0.10.
- The company credits “strong innovation across our client, edge and data center portfolios” for driving double-digit revenue growth in Intel Products.
- Intel’s first quarter revenue and non-GAAP EPS exceeded expectations due to “better-than-expected gross margins and strong expense discipline,” according to CFO David Zinsner.
- Post-market trading saw Intel’s shares fall by 2.3% to $34.29 with 68,682 shares traded. The stock currently holds 11 buys, 33 holds, and 4 sells.
Intel Corp on Smartkarma
On Smartkarma, top independent analyst William Keating published insightful research reports on Intel Corp. One report questioned the transparency of Intel’s new segment reporting, revealing operating losses of approximately $17 billion over three years. The stock price plummeted more than 10% shortly after the revelation. Another report highlighted issues surrounding delays in Intel’s manufacturing plants despite receiving substantial funding through the CHIPS Act. These reports lean bearish on Intel’s future prospects, reflecting concerns within the investment community.
In contrast, analyst Business Breakdowns took a more bullish stance, debating whether Intel’s current performance reflects a cyclical recovery or signals secular demise. Furthermore, Baptista Research‘s report highlighted Intel’s solid progress in AI and cloud technology, showcasing consistent growth in revenue and successful execution of the IDM 2.0 strategy. These varying opinions and analyses provide investors with valuable insights into Intel’s current challenges and opportunities in the ever-evolving semiconductor market.
A look at Intel Corp Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 4 | |
Dividend | 3 | |
Growth | 2 | |
Resilience | 3 | |
Momentum | 2 | |
OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Intel Corporation, a leading company in the computer components industry, has received a mix of Smart Scores indicating its long-term outlook. With a high Value score of 4, Intel is seen as competitively priced relative to its fundamentals. Its Dividend score of 3 suggests a moderate dividend payout consistency. However, the Growth score of 2 and Momentum score of 2 hint at challenges in terms of future growth opportunities and short-term performance. In terms of resilience, Intel scores a 3, reflecting a stable operational capacity in uncertain market conditions.
Overall, Intel Corporation continues to be a strong player in the market with a diverse product portfolio including microprocessors, chipsets, and network products. While its value is recognized with a high score, the company may face hurdles in driving growth and maintaining momentum. Investors interested in stable returns and a company with a solid foundation may find Intel appealing, considering its strong emphasis on value and a respectable dividend payout.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars